• Grape seeds procyanidins |
• Venous thrombosis induced by inferior vena cava ligation in rats before treatment with grape seed procyanidins |
• Decreased thrombus weight |
• Improvement of endothelial function |
Zhang et al. (2011)
|
• 14-Day oral treatment at a dose of 400 mg/kg after vena cava ligation |
• Therapeutic model |
• Suppression of P-selectin, vWf, VCAM-1, and ICAM-1 expression on vessel wall |
• Anti-inflammatory effect |
• Increased expression of ADAMTS13 (responsible for degradation of vWf multimers to shorter fragments, limits the procoagulant activity of vWf) on the vessel wall |
• Increased endothelial cell integrity |
• Counteraction against leukocyte adhesion to endothelium |
• Decreased serum level of proinflammatory cytokines: IL-6, IL-8, and TNFα |
• Grape seed procyanidins |
• Venous thrombosis induced by inferior vena cava ligation in rats after treatment with grape seed procyanidins |
• No effect on thrombus weight |
• Improvement of endothelial function caused mainly by the increase in NO release |
De Curtis et al. (2003)
|
• 30-Day oral treatment at a dose of 3.4 g/rat or single intravenous injection at a dose of 5–15 mg/kg before vena cava ligation |
• Preventive model |
• Prolongation of bleeding time |
• No changes in APTT, PT, and platelet adhesion to collagen |
Arterial thrombosis |
• Extract from Potentilla erecta rhizome |
• Electrical-induced thrombosis, rat carotid artery |
• Decreased thrombus weight |
• Platelet inhibition |
Marcinczyk et al. (2017)
|
• 14-Day oral treatment at a dose of 400 mg/kg |
• Preventive model |
• Prolonged time to artery occlusion |
• Inhibition of thromboxane synthesis |
• Extract from Potentilla erecta rhizome |
• Electrical-induced thrombosis, rat carotid artery |
• Increased thrombus weight |
• Enhanced fibrin formation |
Marcinczyk et al. (2021a)
|
• 14-Day oral treatment at a dose of 200 mg/kg (STZ-induced diabetic rats) |
• Preventive model |
• Attenuated fibrinolysis |
• Corilagin |
• Electrical-induced thrombosis, rat carotid artery. Therapeutic model |
• Restoring the blood flow in the occluded rat carotid artery |
• Enhancement of fibrinolytic response |
Shen et al. (2003)
|
• Single intravenous injection at a dose of 1.25–5 mg/kg after thrombus formation |
• Thrombolytic effect at a dose of 5 mg/kg was comparable to the thrombolytic effect after urokinase (20,000 U/kg) administration |
• No changes in ADP-induced, AA-induced, or PAF-induced rabbit platelet aggregation in vitro
|
• Grape seed procyanidins |
• Helium-neon laser + Evans blue-induced thrombosis in a mouse carotid artery |
• Decreased thrombus size |
• Platelet inhibition |
Sano et al. (2005)
|
• Single intraarterial injection at a dose of 20 mg/kg or two oral administrations (2 × 200 mg/kg with 30-min interval) |
• Preventive model |
• Reduced shear-stress-induced platelet activation ex vivo after repeated oral administration |
Other models |
• Extract from P. erecta rhizome |
• Ferric chloride-induced thrombosis, mouse mesentery vein |
• Decreased PS exposure |
• Platelet inhibition |
Marcinczyk et al. (2017)
|
• 2-day oral treatment at a dose of 400 mg/kg |
• Parietal thrombus |
• Reduced the extent of PS exposure at a dose of 400 mg/kg to the extent comparable to aspirin (one single oral administration, 100 mg/kg) |
• Inhibition of thromboxane synthesis |
|
• Preventive model |
• Extract from P. erecta rhizome |
• Laser-induced thrombosis |
• Decreased thrombus area (100 mg/kg) |
• Platelet inhibition |
Marcinczyk et al. (2021a)
|
• 14-day oral treatment in STZ-induced diabetic mice |
• Preventive model |
• Decreased P-selectin secretion (100 mg/kg, 400 mg/kg) |